For Immune System Stem Cell Studies, Mice Aren’t Enough – Science 2.0
|
For Immune System Stem Cell Studies, Mice Aren’t Enough
Science 2.0 Stem cell therapy is all the rage, with suspect companies sprouting up like supplement stores, claiming to be a benefit for this and that. Often all they have are mouse studies and FDA disclaimers on their side. That’s not to say mouse studies are not … |
|
Stem Cell Institute of America – August 23, 2017
9NEWS.com Dr. Pellow and his team are offering free educational seminars about Stem Cell Therapy for Pain Centers. You can find the full list of upcoming events online at www.StemCellTherapyForPain.com then click on “Stem Cell Events” and “Denver”. Take the … |
lareviewofbooks |
CRISPR, Patents, and Nobel Prizes
lareviewofbooks Nor is this a “how to” book for aspiring do-it-yourself CRISPR users; or a deep analysis of the ethical, legal, and social issues CRISPR and its progeny will raise; or a legal analysis of the already (in)famous CRISPR patent fight; or a look at the … |
lareviewofbooks |
CRISPR, Patents, and Nobel Prizes
lareviewofbooks Nor is this a “how to” book for aspiring do-it-yourself CRISPR users; or a deep analysis of the ethical, legal, and social issues CRISPR and its progeny will raise; or a legal analysis of the already (in)famous CRISPR patent fight; or a look at the … |
Hemophilia News Today |
uniQure Updates Gene Therapy Program in Treatment of Hemophilia B
Hemophilia News Today Recent advances in gene therapy approaches to treat hemophilia B were recently announced by uniQure. The company achieved “substantial progress in advancing our lead program in hemophilia B,” Matthew Kapusta, CEO of uniQure, said in a press … |
Hemophilia News Today |
uniQure Updates Gene Therapy Program in Treatment of Hemophilia B
Hemophilia News Today Recent advances in gene therapy approaches to treat hemophilia B were recently announced by uniQure. The company achieved “substantial progress in advancing our lead program in hemophilia B,” Matthew Kapusta, CEO of uniQure, said in a press … |
UC Berkeley |
Cyborg bacteria turn sunlight into useful chemicals
UC Berkeley “Synthetic biology and the ability to expand the product scope of CO2 reduction will be crucial to poising this technology as a replacement, or one of many replacements, for the petrochemical industry,” he said. Sakamoto and Yang presented their work … ‘Cyborg’ bacteria beat plants at their own gameChemistry World (subscription) Semiconductor nanoparticles give bacteria a boostThe Engineer |
UC Berkeley |
Cyborg bacteria turn sunlight into useful chemicals
UC Berkeley “Synthetic biology and the ability to expand the product scope of CO2 reduction will be crucial to poising this technology as a replacement, or one of many replacements, for the petrochemical industry,” he said. Sakamoto and Yang presented their work … ‘Cyborg’ bacteria beat plants at their own gameChemistry World (subscription) Semiconductor nanoparticles give bacteria a boostThe Engineer |